ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The Cochlear Limited (ASX: COH) share price was trading 19.25% lower today following the release of news it would suspend its profit guidance for FY20.
The All Ordinaries (ASX: XAO) was trading 1.9% higher today at lunch, with shares of TPG Telecom Ltd (ASX: TPM), Fortescue Metals Group Limited (ASX: FMG) and RESMED/IDR UNRESTR (ASX: RMD) moving and shaking the Australian share market.
The ResMed (ASX:RMD) share price was trading 2.63% higher today following as news of its quarterly financial report continue to buoy the speed device maker.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.18% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.64% at lunch.
The ResMed Inc (ASX:RMD) share price shot up 14% this morning after releasing a strong first-quarter result.
Cochlear Limited (ASX:COH) shares were down 4% today following their Annual General Meeting (AGM). Is it time to buy Cochlear shares?
If you’re looking for growth in your portfolio, you may have considered ResMed Inc (ASX: RMD) or Ramsay Health Care Limited (ASX: RHC). Here’s which one I would pick.
ResMed Inc (ASX:RMD) announced the fourth quarter result of its 2019 financial year.
